the aid library

Filter

387

Executive summary: the selection and use of essential medicines 2021

World Health Organization WHO (2021) C_WHO

Report of the 23rd WHO Expert Committee on the selection and use of essential medicines This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc) ... more

Statistical Yearbook for Asia and the Pacific 2014

United Nations Economic and Social Commission for Asia and the Pacific (2014) C2

HIV in Asia and the Pacific

UNAIDS (2013) C2

UNAIDS Report 2013

Compendium of good practices in the health sector response to HIV in the WHO European Region

Dr. M. Dara; Z. T. Gavry; M. Mansfeld World Health Organization (Europe) (2018) C_WHO

Meeting of national HIV programme managers of Eastern European, Central Asian and non-EU/EEA countries

World Health Organization (Europe) (2018) C_WHO

Meeting report, 25-26 September 2017 Copenhagen, Denmark

The Global State of Harm Reduction 2016

K. Stone; G. Sander Harm Reduction International (2016) C2

The Georgian national HIV/AIDS strategic plan for 2016–2018

CCM Georgia (2019) C2

Endorsed by the CCM Georgia on April 15th 2015 Accessed: 26.09.2019

Modelling an Optimised Investment Approach for Tajikistan

The Republic of Tajikistan; UNDP (2014) C2

Getting to Zero Sustainable Financing of National HIV Responses

Legal environment Assessment for HIV in Ukraine

USAID (U.S. President’s Emergency Plan for AIDS Relief) (2017) C2

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis (CDC)

Centers for Diseases Control and Prevention (2019) C_CDC

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Accessed: 08.10.2019

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV - Interim Guidelines

World Health Organization (WHO) World Health Organization (WHO) (2018) C_WHO

Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection HIV Treatment

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO

Accessed: 19.10.2019

Integration of Gender and Human Rights in HIV and Sexual and Reproductive Health Services

R. Clarke; S. Caffe; A. Guedes; et al. Pan American Health Organization; (Regional Office of the World Health Organization); UN Women (United Nations for Gender Equality and the Empowerment of Women) (2013) C2

Training for Health Care Providers Facilitators’ Manual

WHO Prequalification of Diagnostics Programme -Public Report (Product: BD FACSPrestoTM Near-Patient CD4 Counter System, PQ number: PQDx 0197-045-00)

World Health Organization (2016) C_WHO

PQDx 0197-045-00 WHO PQDx PR March /2016, version 2.0

WHO Prequalification of In Vitro Diagnostics Programme - Public Report (Product: MP Diagnostics HIV Blot 2.2, Number: PQDx 0198-071-00)

World Health Organization (2016) C_WHO

PQDx 0198-071-00 WHO PQDx PR April/2016, version 2.0

Fast-tracking HIV treatment: Parliamentary action and policy options

P. Bayr; L. Davies; F. Ndugulile; et al. Inter-Parliamentary Union (For democracy, For everyone); UNAIDS (2015) C2

Progress report on HIV, viral hepatitis and sexually transmitted infections, 2019

World Health Organization (2019) C_WHO

Accountability for the global health sector strategies, 2016–2021 WHO/CDS/HIV/19.7

Using TRIPS flexibilities to improve access to HIV treatment

UNAIDS (Joint United Nations Programme on HIVAIDS); World Health Organization; UNDP (2019) C2

Policy Brief Accessed: 20.11.2019

On the Fast-Track to end AIDS

UNAIDS (2019) C2

UNAIDS | 2016–2021 Strategy Accessed: 20.11.2019

The sustainable development goals and the HIV response

UNAIDS (Joint United Nations Programme on HIVAIDS) (2019) C2

Stories of putting people at the centre Accessed: 20.11.2019